Биохимическая Лаборатория

Профессор – Заведующий Оделением: Михаил Карамузис

Цели

Целью биохимической лаборатории является проведение пациентам амбулаторных клиник биохимических исследований , подготовка врачей-ординаторов и студентов-медиков по вопросам клинической биохимии а также участие в научно- исследовательских программах и конференциях для улучшения методов проведения биохимических анализов.

Сотрудники лаборатории биохимии


Врачебный коллектив:
  1. Михаил Карамузис, профессор клинической химии- заведующий отделением тел.2310999109, электронная почта: mkaram@med.auth.gr
  2. Тисиаду Екатерина - Куратор , электронная почта: thisiadou@yahoo.gr Tel.2310-993541
  3. Папе-Магда Куратор B ', электронная почта: elanos@hol.gr Tel.2310-993541

Другие Научные сотрудники:
  1. Цобанопулу Эльвира-биолог

Ординаторы:
  1. Антониаду Зои
  2. Далавициью Василики
  3. Димитриадис Павлос

Технолог, лаборанты :
Телефоны 2310-993555 ,2310-993554
  1. Агапи Василиаду
  2. Георгиаду Левкотея
  3. Пасхалина Кабусу
  4. Компиду Эфросини
  5. Ладопулу Деспина
  6. Лазариду Партена
  7. Макровасили Георгия
  8. Самара Афанасия
  9. Анастасия Триандафилиду
  10. Анна Цоха
  11. Филипу Георгиос
  12. Хатцопулу Поликсени

Отделы Лаборатории Биохимии:
  1. Отдел стандартных биохимических анализов
  2. Отдел специфических иммунологических тестов
  3. Отдел определения состава лечебных препаратов
  4. Отдел исследования биологических жидкостей
  5. Отдел иммуноферментных анализов (ELISA)
  6. Отдел специфических биохимических исследования

Научные работы Лобораторного Сектора, которые были опубликованы в международных журналах за последние годы

1) Abnormal Insulin secretion in multiple sclerosis S. Balojannis, M. Karamouzis, Ag. Diakojannis and A. Trakatellis. Neurologia et Psychiatrica, 1978; 1(44): 144-148 (I.F. 0,642)

2) Modifications du taux de la testosterone serique avant et pres adenomectomie prostatique. J. Manikas, A. Kalinderis, M. Karamouzis et G. Hatzichristou. Extrait du LYON CHIRURGICAL 1985; 81(1): 61-63

3) Evaluation of the tumor marker CA 19-9 in the Diagnosis of the pancreas. C. Arvanitakis, A. Nikopoulos, E. Giannoulis, M. Karamouzis, C. Semoglou, A. Theoharidis, A. Tourkantonis. Proceedings of Tumor Associated Antigens, Oncogenes, Recepetors, Cytocynes in tumor Diagnosis and Therapy at the Beginning of the Nineties, 1991; 16-19

4) The value of the determination of serum bone GLA-protein (BGP) in advanced chronic renal failure. M. Pyrpasopoulos, M. Karamouzis, S. Kapoulas, A. Papagianni, A. Dimitriadou, A. Trakatellis. - Clinical nephrology 1989; 31(5): 275 I.F. 1, 418 – - Πρακτικά του 2ου Βορειοελλαδικού Ιατρικού Συνεδρίου. 1985; τόμος Β: 206-209 (πλήρως).

5) Α pilot study of Piracetam in Cyprophan Hemodialysis D. Grekas, P. Alivanis, M. Karamouzis, M. Pyrpasopoulos and A. Tourkantonis. Artificial organs 1989; 13(5): 422-426. (I.F. 1, 298)

6) Anxiolysis as a modifying factor or certan neuropsychiatric parameters in patients with company heart disease. D. KARAKOSTAS, C.L. PAPADOPOULOS, A. MISSIOPOULOU-KOKKA, A. VASSILOPOULOS, Μ. KARAMOUZIS, J. GIANNAKOULIS, A. DIMITRIADOU-VAFIADOU, G. SAKADAMIS. Acta Therapeutica, 1988; 14(4): 381-388. (I.F. 1, 998)

7) Effects of famotidine on gastric mucus of the rat Ε. Eleftheriadis, K. Kotzampassi, V. Tziounta, M. Karamouzis. Res. Exp. Med. 1990; 190: 219-222 (I.F. 0,769).

8) Acute cyclosporin-A Renal dysfaction in dogs reversed by and Calcium - antagonists and antiplatelet agents. D. Grekas, P. Alivanis, H. Kalekou, A. Papayianni, M. Karamouzis, A. Tourkantonis. Renal Failure1992; 14(4): 493-498 (I.F. 2,590).

9) Changes in atrial natriuretic peptide (α-ANP) in long distance swimmers M. Karamouzis, K. Mandroukas, A. Deligianis and A. Dimitriadou-Vafiadou. Biochemical laboratory Univ. of Thessaloniki. Clinical Chemistry and Enzymology Communications, 1994; 6: 191-195. (I.F. 1,523)

10) Τhe action of dynorphin 1-13 on calcium up take by the bovine aortic media Β. Kokkas, A. Kouzoumitzis, M. Kotoula, D. Kouvelas, M. Karamouzis, K. Papadopoulos and A.G. Papadelis. Intern. J. Immunopathology and Pathology, 1991;4(2):91-97 (I.F. 3,927).

11) Plasma TSH, T3, T4 and cortisol responses to swimming at varying water temperature. A. Deligiannis, M. Karamouzis, E. Kouidi, V. Mongios, C. Kallaras. British Journal Sports of Medicine. 1993; 27(4): 247-250. (I.F. 2, 223).

12) Tumor markers monitoring for lung cancer chemotherapy assessment. K. Nenova, M. Karamouzis, D. Kovatchev, A. Dimitriadou, H. Tzekov. Annual proceedings of International medical association 1995;1 (1):74-77.

13) Physical training, growth hormone and testosteron levels and blood pressure in prepubertal, pubertal and adolescent boys. Zakas A, Madroukas K., Karamouzis M., Panagiotopoulou G. Scand. J. Med. Sports 1994; 4:113-118. (Ι.F. 1,989)

14) Atrial natriuretic factor responses to submaximal and maximal exercise K. Mandroukas, A. Zakas, N. Aggelopoulou, K. Christoulas, G. Abatzides and M. Karamouzis British Journal of Sports Medicine, 1995; 29(4): 248-251. (I.F. 2, 223)

15) Altarations in thyroid hormones and thyrotropin (TSH) in morbidly obese patients before and after vertical gastroplasty. S. Papavpamidis, A. Zisiadis, M. Karamouzis, I. Kessisoglou, H. Antoniadou, A. Aidonopoulos. Οbesity surgery, 1995; 5:298-301. (I.F. 3,723)

16) Pacing and atrial natriuretic peptide. C. Papadopoulos, G. Sakadamis, G. Kanonidis, B. Kokkas, G. Kotridis and M. Karamouzis. Europace 1997; 261-265. (I.F. 1,477)

17) ΑΝΡ Concentrations during Interchanging DDD-VVI pacing model in patients with retrograde ventriculoatrial conduction. C. Papadopoulos, B Kokkas, G. Sakadamis, I. Kanonidis, P. Kotridis, M. Karamouzis, G. Koukoulenidis, N Nikolaidis, A. Missopoulou and C. Gitsiou. Acta Cardiologica, 1997; L 11: 37-47. (I.F. 0,588)

18) Endothelin in renal transplant patients. D. Grecas, G. Bamihas, M. Karamouzis, D. Bacharaki, N. Savidis, A. Tourkantonis. Transplantation proceeding 1999; 31: 1703-1705. (I.F. 0,588)

19) Piracetam as a potent inhibitor of plasma thromboxane B2 during Hemodialysis. D. Grekas, P. Alivanis, M. Karamouzis, M. Pyrpasopoulos. Δημοσιεύθηκε στο Nephron 1989; 52: 372-373. (I.F. 1,097)

20) Effects of azathioprine on cyclosporin metabolism D. Drekas, P. Νikolaidis, M. Karamouzis, P. Alivanis, A. Tourkantonis. Nephron 1992: 60:489. (I.F. 1,097)

21) Histamine and serotonin in uremic pruritus: Effects of Ondansetron in CAPD-Pruritic patients. E. Balaskas, G. Bamihas, M. Karamouzis, G. Voyiatzis, A. Tourkantonis. Nephron 1998;78:395-402. (I.F. 1,097)

22) Effect of the β1 blocker/β2-Agonist celiprolol on Atrial Nutriuretic peptide plasma levels in Hypertensive patients. C. Papadopoulos, B. Kokkas, M. Karamouzis, M. Haldones, A. Platis, G. Dadoush, I. Kanonidis. Cardiovascular Drugs and Therapy 1998; 12:345-346. (I.F. 1,396)

23) Α comparative study of the influence of dynamic and static isometric intermitten contractions on the intramuscular accumulation of prostaglandins and thromboxanes. A study with microdialysis. M. Karamouzis, H. Lanberg, M. Kjaer, J. Bulφw an B. Saltin. Medical Biochemistry 1999; (1): 233-242. (I.F. 2,421)

24) Metabolism and inflammatory mediators in the peritendious space measured by microdialysis during intermittent issometric exercise in humans. Langberg H, Skovgaard D, Karamouzis M, Bόlow J and Kjaer M. Journal of Physiology 1999; 3:919-927. (I.F. 4,352)

25) Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. Nousia-Arvanitaki S, Galli-Tsikopoulou A, Dracoulacos Dr., Karamouzis M and Dimitriadou A. Journal pediatric endocrinology and metabolism 2000; 13(4): 319-324. (I.F. 0,81)

26) Autoantibodies predicting diabetes mellitus type I in colliac disease. Gallis-Tsinopoulou A, Nousia-Arvanitakes S, Dracoulacos D, Xefteri M and Karamouzis M. Hormone Research 1999; 52: 119-124. (I.F. 1,385)

27) Osteopenia in Children and adolescents having hyperprolactinaemia. Galli-Tsinopoulou A, Nousia-Arvanitaki S, Karamouzis M, Dimitriadou A. Journal of pediatric endocrinology and metabolism 2000; 13(4): 439-441. (I.F. 0,811)

28) Are serum melatonin levees a market for the differential diagnosis of dementia. Tsolani M., Karamouzis M., Fountolakis K., Iakobidou V., Kazis A. German Journal of Psychiatry 2000; 3(2): 2-12

29) Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D., Kalevrosoglou I., Karamouzis M., Geropoulou E., Kabouris H. and A. Tourkantonis. Clinical Nephrology 2001;55:115-120. (I.F. 1,418)

30) The response of muscle interstitial prostglandin E2 (PGE2), Prostacyclin I2 (PGI2) and thrombokane A2 (TXA2) levels during incremental dynamic exercise in humans. Determined by in vivo microdialysis. Karamouzis M., Karamouzis I., Vamvakoudis E., Ampatzidis G., Christogelas K., Aggelopoulou N., Giannoulis E. and Mandroukas K. Prostagladines Leukotrienes and Essential Fatty Acids 2001; 64(4 και 5): 259-263. (I.F. 3,123)

31) Morning an evening plsma melatonin and dekamethasone supression test in non-seasonal major depressive patients from northern Greece (Latitude 40-41, 5o). Fountoulakis K., Karamouzis M., Iakobides J., Diakogiannis J., Kaprinis G., Dimitriadou A., Bech P. Neuropsychobiology 2001; 44: 113-117. (I.F. 2,367)\

32) In situ microdialysis of intramuscular prostaglandin and thromboxane in contracting skeletal muscle in humans. Μ. Karamouzis, H.Langberg, D. Skovgaard, J. Bόlow, M. Klaer, and B. Saltin. Akta phsyiol Scand 2001 : 171 : 71-76 (I.F. 2,230)

33) Relationship between pupilometric findings DST and melancholia. Fountoulakis K., Fotion F., Iacovides A., Karamouzis M., Goneas A., Demetriadou A., Kaprinis G. Acta psychiat. 2001; 101:222-235. (I.F. 2,356)

34) The effects of marathon swimming on serum leptin and plasma neuropeptid and levels. Karamouzis I., Karamouzis M., Vrabas I., Christoulas K., Kyriazis N., Giannoulis E. And Mandroukas K. Clinical Chemistry and Laboratory Medicine 2002;40(2):132-136 (I.F. 1,725)

35) Plasma Atrial natriuretic peptide levels in essential hypertension after treatment with verapamie. Κόκκας Β., Kotridis P., Karamouzis M., Kanonidis I., Sakadamis G., Dadous G., Haritos S., Kyriakou P., Theodosiadis I., Papadopoulos P., Mirtsou-Fidani V., Papadopoulos C. European Journal of drug metabolism and pharmacokinetics 2002; 27(1):45-48. (I.F. 0,479)

36) Plasma Artial Natriuretic Peptide in Essential Hypertension after treatment with Irbesartan. Kotridis P, kokkas B., Karamouzis M., Sakadamis G., Kanonidis I., Dadous G., Karantona C., Gouli O., Karadoumakis J., Papadopoulos C. P., Papadopoulos L. C. Epitheorese Klinikes Farmakokinetikes, International Edition 2002; 16; 75-76. (I.F. 0, 474)

37) Hormonal responses after a muscular endurance resistance exercise protocol in elderly males. Smilios I., Tokmakidis Σ., Donda H., Parlavantzas A. and Karamouzis M. Medicine and Science in Sports and Exercise 2003;35(4):644-654. (I.F. 2,909)

38) Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. S. Nousia - Arvanitakis, A Galli-Tsinopoulou and M. Karamouzis. Acta Paediatrica 2001; 90(5):515-519 (I.F. 1,124)

39) Plasma Artial Natriuretic Peptide in Essential Hypertension after Treatment with terazocin. P. Kotridis, B. Κόκκας, Ρ. Κυριακού, M. Karamouzis, G. Salpigides, C. Karantona, J. Karadoumanis, G. Ginis, O. Goulis, P. C. Papadopoulos, C. Vakalopoulos, G. Sakantamis, A. Dimitriadou, V. Mirtsou - Fidani, C. L. Papadopoulos. European Journal of drug metabolism and phramacokinetics 2003; 28(2):143-146. (I.F. 0,479)

40) Plasma artial natriuretic peptide in essential hypertension after treatment with irbesartan. Kotridis P, Kokkas B, Karamouzis M, Sakadamis G, Kanonidis I, Karadona C, Gouli O, Karadoumanis J, Papadopoulos P.C., Papadopoulos C.L. Blood Press 2002; 11(2):91-4. (I.F. 1,124)

41) The influence of continuous seved-day elevated intra-abdominal pressure in the renal perfussion in cirrotic rats. Katerina Kotzampassi, George Metaxas, Daniel Paramythiotis, Ifigenia Pidonia, Helen Rekka, Michael Karamouzis and Efthimios Eleftheriadis. Journal of surgical Research 2003; 115:133-138. (I.F. 1,735)

42) Insoulin resistance and hyperinsulinemia in pepubertal obese Galli-Tsinopoulou A., Karamouzis M., Nousia Arvanitakis S. J. Pediatr Endocrinol Metabol. 2003; 16(4):555-60. (I.F. 0,811) Η εργασία αυτή βραβεύθηκε από την Ακαδημία Αθηνών στις 30-12-2004.

43) Relationship among Dexamethasone suppression rest, personality disorders and stressful life events in clinical subtypes of major depression: An exploratory study. K. Fountoulakis, A. Iacovides, F. Fotiou, M. Karamouzis, A. Demetriadou and G. Karpinis. Annals of General Psychiatry. 2004; 3:15-23 (I.F. 10,519).

44) Inracerebroventricular administration of atrial natriuretic peptide preventsincrease of plasma ADH, aldosterone and corticosterone levels in restrained dehydrated rabbits. Kallaras C, Angelopoulos N, Bountzioukas S, Mavroudis K, Karamouzis M, Guiba-Tziampiri O. Journal of Endocrionological Investigation 2004; 27:844-853. (I.F. 1,469)

45) Cardiac function after exhaustive open-sea swimming. Alexiou S., Kouidi E., Fahadidou – Tsieigiroglou, Karamouzis M., Deligiannis A. Sports med phys fitness 2005; 45: 98-104.

46) Effects of variation of artioventricular interval of left vetricular diastolic filling dynamics and atrial natriuretic peptide levels in patients with DDD pacing for complete heart block Styliadis I., Gouzoumas N., Karnounis H., Papadopoulos Chr., Efthimiadis G., Karamouzis M., Parharidis E. and Louridas G. Europace 2005; 7(6): 576-583. (I.F. 1,477)

47) Anticarcinogenic and antiplatellet effects of carvacrol. Karkabounas S., Kostoula O., Daskalou T., Veltsistas P., Karamouzis M., Zelovitis I., Metsios A., Lennas P., Evangelou A.M., Kotsis N., Skoufas I. Experimental Oncology 2006; 28(2): 121-129.

48) Multifollicular ovaries in female adolescents with cystic fibrosis. Galli-Tsikopoulou A., Moudiou T., Mamopoulos A., Karamouzis M. and Nousia-Arvanitaki. Fertil Stertil 2006; 85(5): 1484-1487. (I.F. 3,277)

49) Similar pattern of diastolic function adaptation of both utricles to programmed atrioverntricular interval modification in patients with DDD pacing. Stuliadis I., Papadopoulos Chr., Gouzoumas N., Giannakoulas G., Karvounis H., Karamouzis M., Boufidou A., Parharidis G. Anadolon Cardiol Derg. 2006; 6: 243-247.

50) Evaluation of bone metabolism in children with Acute Lymphoblastic Leuhemia. A 2-year study from Nothern Greece. Tragiannidis Ath., Athanasiadou A., Rousso I., Karamouzis M., Katsos G., Tsitouridis I., Sidi B., Koliouskas D. Pediatr hematol Oncol. 2006; 28(10): 699.

51) Subclinical Exocrine Pancreatic Dysfunction Resulting From Decreased cholecystokinin secretion in Presence of Intestinal Villous Atrophy. Nousia- Arvanitakis S., Fotoulaki M., Tendridou K., Vassilaki C., Agguridaki Ch. and Karamouzis M. Journal of pediatric Gastroenterology and Nutrition 2006; 43: 307-312. (I.F. 2,067)

52) Early Decreases in plama Lipid transfer Proteins During Weight Reducition Tzotzas Th., Dumont L., Triandos A., Karamouzis M., Constantinidis Th. and Lagrost L. OBESITΥ 2006; 14(6): 1038-1045.

53) Atrial Natriuretic Peptide Suppresses Left Ventricular Function and the Renin-Angiotensin- Aldosterone System Activity in Normal and moderately Atherosclerotic Rabbits Kallaras K., Babas G., Stergiou –Michailidou, Karamouzis M., Zaraboukas Th. Review of Clinical Pharmacology and Pharmacokinetics, International Edition 2006; 181-184.

54) Effects of physical training of lipid peroxidation in patients on hemodialysis. I. Karamouzis, A. Sioulis, M. Karamouzis, E. Kouidi, A. Triantos, A. Deligiannis, A. Dimitriadou and D. Grekas. Review of clinical pharmacology and pharmacokinetics, Internal Edition 2006; 198-200.

55) Nebivolol increases ANP plasma levels in hypertensive patients P. Papadopoulos, B. Kokkai, P. Kotridis, G. Aidonidis, V. Koustimanis, D. Karnaras, I. Vogiatzis, G. Dadousi, M. Karamouzis, A. Kouyountris, G. Sakadamis, D. Hatseras, C. Papadopoulos. Review of Clinical Pharmacology and pharmaconinetic International Editiion 2006; 20: 281- 282.

56) Carvediol Increases ANR plasma levels in Hypertensive Patient P. Papadopoulos, P. Kotridis, B. Konnas, V. Koutsimanis, G. Aidonidis, G. Dadousis, O. Gouli, M. Karamouzis, A. Kouyoumtzis, G. Sakadamis, D. Hatseras, C. Papadopoulos. Review of Clinical Pharmacology and pharmaconinetics International Edition, 2006; 20: 283-284.

57) Metaboli effects of prosiglitanone and metformin in Greek patients with recetly Φ Type2 Diabetes. F. Iliadis, N. Kadoglou, A Hatzitolios, M. Karamouzis, M. Alevizos and D. Karamitsos. Δημοσιεύθηκε στο in Vilo 2007; 21: 1107-1114. (Ι.F. 1,273)

58) Carvedilol increases atrial natriuretic peptide plasma levels in hypertensive patients. P. Papadopoulos, P. Kotsidis, B. Kokkas, V. Koutsimanis, G. Aidonidis, C. Padousm, O. Gouli, M. Karamouzis, A. Kouyoumtzis, G. Sakadamis, D. Hatseras and C. Papadopoulos. Δημοσιεύθηκε στο European Journal of Inflammation 2007; 5(2): 97-101.

59) Hormonal Responses after a strength Endurance Resistance Exercise Protocol in Young and Elderly Males. Ι. Smilios, T.Pilianidis, M. Karamouzis, A. Parlavantzas, S. Tokmakidis Int. J. Sport. 2007; 28: 401-406. (I.F. 1, 240)

60) Grelin and leptin levels in obese adolescents. Relationship with body fat and insulin resistance. Ch. Stylianou, A. Galli- Tsinopoulou, D. Farmakiotis, I. Roussos, M. Karamouzis, G. Koliakos, S. Nousia-Arvanitakis. Hormones 2007; 6(4): 295-305.

61) Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods K. Fountoulakis, A. Iakobidis, M. Karamouzis, G. Gerasimou, Ph. Grammatikos, F. Fotiou and G. Kaprinis Journal of Affective Disorders 2007; 99(1): 155-163. (I.F. 3, 138)

62) Season of births, clinical manifestations and Dexamethasone Suppretion Test in unipolar major depression. K. Fountoulakis, A. Iakovidis, M. Karamouzis, G. Kaprinis and Ch. Ierodiakonou. Annuals of General Psychiatry 2007; 6: 20-30.

63) The effects of L-arginine and Aprotinin on Intestinal is Ischemia-reperfusion injury C.P. Spanos, P. Papaconstantinou, P. Spanos, M. Karamouzis, C. Papaconstantinou Gastrointest Surg 2007; 11(3): 247-255.

64) Grelin Serum during oral glucose tolerance test in prepubertal obese children with insulin resistance. A. Gali- Tsinopoulou, C.Stylianou, D. Farmakiotis, I. Roussos, M. Karamouzis, S. Nousia- Arvanitakis. J. Pediartr. Endocrinol Metab. 2007; 20(10): 1081-1083. (I.F. 0, 811)

65) Nebilol increases atrial natriuretic peptide/ systolic blood preasure ratio in mypertensive patient) Papadopoulos P., Kokkas B., Kortidis P., Aidinidis G., Koutsianis V., Karnaras D., Vogiatzis I., Dadousi G., Karamouzis M., Kouyountris A., Sakadamis G., Hatseras D. and Papadopoulos C. European Journal of Inflamation 2008; 6(1): 31-35.

66) Measurement of Endothelin-1, C-reactive protein, Fibrinogent plasma levels in patients with Acute Ischemic stroke. S. Giannopoulos, M. Kosmidou, A. Hatzitolios, Ch. Savvopoulos, A. Ziakas and M. Karamouzis. Neurological Research, 2-10-2007.

67) Increase in Oxidative Stress but not in Antioxidant Capacity with Advancing Stages of Chronic Kidney Disease. Karamouzis I., Sarafidis P., Karamouzis M., Iliadis St., Bettina-Haidich A., Sioulis A., Triantos A., Vavatsi-Christaki N., Grekas D. Am . J. of Nephrol. 2008; 28: 397-404. (Impact factor 2,879)

68) Enhanced oxidative stress with a gradient between plasma and muscle interstitial fluid in patients with end stage renal failure on hemodialysis. Karamouzis I., Grekas D., Karamouzis M., Triantos A., Vasileva-Staikov SV., Kovachev D., Dimitriadou A. Hormones 2008; 7(1): 62-68

69) False Positive tumor markers CA15-3, CEA, CA129 and CA19-9 in patients with homozygous β- Thalassaemia, sickle cell/ β- Thalassaemia and Thalassaemia intermedia. Karamouzis I., F Kesidou, E. Hassapopoulou, C. Manolopoulos, B. Papageorgiou, M. Giannoulis, E. Sampanopoulou, D. Michailidou, Th. Dardavessis, M. Karamouzis and I. Pidonia. Review of Clinical Pharmacology and pharmaconinetics 2008;22(2): 182-184.

70) Measurements of endothelin-1, C-reactive protein a nd fibrinogen plasma levels in patients with acute ischemic stoke. S. Giannopoulos, M. Kosmidou, Al. Hatzitolios, CG.Sapopoulos, A. Ziakas, M. Karamouzis Neurol Res 2008, May 16 (Epud ahead of print) (I.F. 1,573)

71) An audit of tumor marner utilization in Greece. Ntaios G., Hatzitolios A., Chatzinikolaou A., Karalazou P., Savopoulos Chr., Karamouzis M., Pidonia I. European Journal of Internal Medicine 2009; 20: e66-e69.

72) Physical training during hemodialysis treatment has a beneficial effect on the the levels of eicosanoid hormone- like subtances Karamouzis I., Grekas D., Karamouzis M., Kallaras K., Stergiou-Michaelidou V., Kouidi E., Deligiannis A., Vavatatsi-Christaki N. Hormones 2009;8(2):129-137.

73) Atrial natriuretic peptide decreases aorta stiffness in cholesterol-fed anesthetized rabbits. Kallaras K., Babas G., Stergiou – Michailidou V., Karamouzis M. and Zarabonnas Th. Pharmacological Research, 2009.

74) Atrial natriuretic peptide decreases aorta stiffness in cholesterol-fed anesthetized rabbits. Kallaras K, Babas G, Siergiou-Mtchailidou V, Karamouzis M, Zaraboukas T. Pharmacol Res. 2009 Oct;60(4):324-31. Epub 2009 May 13.

75) “Living high - training low" vs. "living high - training high": erythropoietic responses and performance of adolescent cross-country skiers. Christoulas K, Karamouzis M, Mandroukas K. J Sports Med Phys Fitness. 2011 Mar;51(1):74-81.

76) Response of biochemical markers of bone turnover to oral glucose load in diseases that affect bone metabolism. Yavropoulou MP, Tomos K, Tsekmekidou X, Anastasiou O, Zebekakis P, Karamouzis M, Gotzamani -Psarrakou A, Chassapopoulou E, Chalkia P, Yovos JG. Eur J Endocrinol. 2011 Jun;164(6):1035-41. Epub 2011 Apr 4.

77) Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy. Tragiannidis A, Dokos Ch, Sidi V, Papageorgiou T, Koliouskas D, Karamouzis M, Papastergiou Ch. Tsitouridis I, Katzos G, Rousso I, Athanassiadou-Piperopoulou F. Hlppokratia, 2011 Jan;15(1):43-7.

78) Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. Karamouzis I., Pervanidou P., Berardelli R, lliadis S, Papassotiriou I, Karamouzis M, Chrousos GP, Kanaka-Gantenbein.C. Horm Metab Res. 2011 Aug; 43(9): 607-13. Epub 2011 Aug.5

79) Βrain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies. TragiannjdisA, Dokos C, Tsotoulidou V, Giannopoulos A, Pana ZD, Papageorgiou T, Karamouzis M., Athanasiadou F. Minerva Paidatr. 2012; 64(3): 307-312